Rheumatoid Arthritis Clinical Trials in New York

Showing 781-800 of 3,596 trials

A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

NCT05049850

The purpose of this study is to assess whether imlifidase in combination with bortezomib, belatacept, rituximab and IVIg can suppress donor specific antibodies (DSA) and the occurrence of antibody-mediated rejection (AMR) in highly sensitized patients with chronic kidney disease with a positive crossmatch towards their living donor during a period of 3 months from transplantation.

Kidney Transplantation in Highly Sensitized Patients

Hansa Biopharma AB3 participantsStarted Dec 2022

New York, New York, United States

Active Not RecruitingPhase 1< 1 mile

A Study of Sovilnesib in Subjects With Ovarian Cancer

NCT06084416

This is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels to establish the Recommended Phase 2 Dose (RP2D) of sovilnesib in subjects with high grade serous ovarian cancer (HGSOC).

High Grade Serous Adenocarcinoma of OvaryFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more

Volastra Therapeutics, Inc.120 participantsStarted Apr 2024

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +10 more locations

A Study to Investigate DSA Rebound in Patients Treated With Imlifidase Prior to Transplantation

A Study of Sovilnesib in Subjects With Ovarian Cancer

Rheumatoid Arthritis Trials in Other Cities

Propranolol Treatment for Postoperative Chylothorax

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

Retro Comparison of Subsidence Following Interbody Devices in Lumbar Spine

Healthcare Integrity & Anti-Fraud Enforcement

Integrated Model for Promoting Parenting and Early School Readiness in Pediatrics

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

BI655130 (SPESOLIMAB) Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment

Effisayil™ 1: A Study to Test Spesolimab (BI 655130) in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis

Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)

GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

Can Mobilizations Applied to the Thoracic Spine Improve Oxygen Saturation Levels and Thoracic Kyphosis in E-Cigarette Smokers?

PUSH-IT Continuing Enteral Feeds for Tracheostomy

Trial of Indication-Based Transfusion of Red Blood Cells in ECMO

Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients

Inappropriate Sinus Tachycardia Registry

Other Conditions in New York